News >

IKZF1 Deletions Predict Poor Prognosis in Pediatric ALL

Jason Harris
Published: Tuesday, Mar 06, 2018

mcl
IKZF1 deletions that co-occurred with deletions in CDKN2A, CDKN2B, PAX5, or PAR1 in the absence of ERG deletion (IKZF1plus) were associated with a dramatically reduced prognosis in pediatric patients with B-cell precursor (BCP) acute lymphoblastic leukemia (ALL).

,” wrote Stanulla et al.
Stanulla M, Dagdan E. Zaliova M, et al. IKZF1plus defines a new minimal residual disease–dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia [published online March 2, 2018]. J Clin Oncol. doi: 10.1200/JCO.2017.74.3617.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of ImmunotherapyAug 13, 20191.5
Advances in™ Multiple Myeloma: Changing Treatment Paradigms and the Emerging Potential of CAR T-Cell TherapyAug 30, 20191.5
Publication Bottom Border
Border Publication
x